Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Metabolism & Toxicology|December 12, 2017
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Ilaria Motta, Andrea Calcagno, Stefano Bonora
The New Microbiologica|September 26, 2018
Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic reviewMonica Sañé Schepisi, Ilaria Motta, Simone Dore, et al.
Le Infezioni in Medicina|December 25, 2015
A probable drug-to-drug interaction between voriconazole and haloperidol in a CYP2C19 poor metabolizing patient. [corrected]Ilaria Motta, Andrea Calcagno, Lorena Baietto, et al.
Le Infezioni in Medicina|June 24, 2014
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelinesFrancesco Giuseppe De Rosa, Ilaria Motta, Silvia Corcione, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2015
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCsLorena Baietto, Andrea Calcagno, Ilaria Motta, et al.
BMC Infectious Diseases|December 3, 2013
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxisFrancesco Giuseppe De Rosa, Ilaria Motta, Ernesta Audisio, et al.
PLOS Global Public Health|March 24, 2023
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosisSedona Sweeney, Catherine Berry, Emil Kazounis, et al.
BMJ Open|September 7, 2021
Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trialBern-Thomas Nyang'wa, Frank Kloprogge, David A J Moore, et al.
Le Infezioni in Medicina|September 24, 2015
Wound botulism after traumatic open fracture in ItalyFrancesco Giuseppe De Rosa, Maria Laura Stella, Sara Astegiano, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2013
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysisAndrea Calcagno, Jessica Cusato, Marco Simiele, et al.
Pageof 4